stage IA cervical cancer
Showing 1 - 25 of >10,000
Human Papilloma Virus Circulating Tumor DNA in Cervical Cancer
Recruiting
- Cervical Adenosquamous Carcinoma
- +26 more
- Biospecimen Collection
-
Rochester, MinnesotaMayo Clinic in Rochester
Jan 4, 2023
Patients With Neuroendocrine Cancer of the Cervix
Recruiting
- Cervical Large Cell Neuroendocrine Carcinoma
- +21 more
- Follow-Up
- Medical Chart Review
-
Houston, TexasM D Anderson Cancer Center
Dec 5, 2022
Among Reproductive Age Gynecological and Breast Cancer
Recruiting
- Anatomic Stage I Breast Cancer AJCC v8
- +29 more
- Healthcare Activity
- Survey Administration
-
Houston, TexasM D Anderson Cancer Center
Nov 2, 2022
Malignant Female Reproductive System Tumor, Stage I Cervical Cancer AJCC v8, Stage I Uterine Corpus Cancer AJCC v8 Trial in
Recruiting
- Malignant Female Reproductive System Neoplasm
- +44 more
- Counseling
- +2 more
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Feb 25, 2022
Remote Telemonitoring of Patient-Generated Physiologic Health
Recruiting
- Clinical Stage 0 Esophageal Adenocarcinoma AJCC v8
- +171 more
- Patient Monitoring
- Questionnaire Administration
-
Duarte, CaliforniaCity of Hope Medical Center
Aug 15, 2022
Cervical Cancer Trial in Shanghai (Total Laparoscopic or Robotic Radical Hysterectomy, Total Abdominal Radical Hysterectomy)
Recruiting
- Cervical Cancer
- Total Laparoscopic or Robotic Radical Hysterectomy
- Total Abdominal Radical Hysterectomy
-
Shanghai, ChinaThe Obstetrics and Gynecology Hospital of Fudan University
Nov 2, 2021
Lymphedema, Stage 0 Cervical Cancer, Stage 0 Uterine Corpus Cancer Trial in Philadelphia (Management of Therapy Complications,
Terminated
- Lymphedema
- +18 more
- Management of Therapy Complications
- Quality-of-Life Assessment
-
Philadelphia, PennsylvaniaGynecologic Oncology Group
Jun 11, 2021
Cervical Adenocarcinoma, Cervical Adenocarcinoma In Situ, Cervical Intraepithelial Neoplasia Trial in Houston (Biospecimen
Recruiting
- Cervical Adenocarcinoma
- +54 more
- Biospecimen Collection
- Laboratory Biomarker Analysis
-
Houston, Texas
- +1 more
Nov 30, 2020
Endometrial Carcinoma, Stage 0 Fallopian Tube Cancer AJCC v7, Stage I Fallopian Tube Cancer AJCC v6 and v7 Trial in New
Withdrawn
- Endometrial Carcinoma
- +55 more
- Internet-Based Intervention
- +3 more
-
New Brunswick, New JerseyRutgers Cancer Institute of New Jersey
Apr 16, 2021
Endometrial Tumors, Endometrial Tumor Malignant, Endometrial Tumor Malignant Stage I Trial in Beijing (Indication-extended
Recruiting
- Endometrial Neoplasms
- +4 more
- Indication-extended Fertility-sparing Therapy
-
Beijing, Beijing, ChinaPeking University People's Hosoital
Jul 12, 2023
Cervical Cancer Trial in Amsterdam (Anti-PD-1 antibody balstilimab)
Not yet recruiting
- Cervical Cancer
- Anti-PD-1 antibody balstilimab
-
Amsterdam, NetherlandsAmsterdam UMC
Oct 17, 2023
Magnetic Resonance Fingerprinting for Preoperative Evaluation of
Recruiting
- Cervical Cancer
-
Roma, ItalyFondazione Policlinico Universitaro "A. Gemelli" IRCCS
Mar 29, 2023
Cancer Survivor, Endometrial Carcinoma, Stage I Uterine Corpus Cancer AJCC v7 Trial in Palo Alto, San Jose (Communication
Active, not recruiting
- Cancer Survivor
- +6 more
- Communication Intervention
- +5 more
-
Palo Alto, California
- +1 more
Oct 24, 2022
Cervical Cancer Trial in Guangzhou (Type B resection or type C resection of the anterior leaf of vesicouterine ligament during
Recruiting
- Cervical Cancer
- Type B resection or type C resection of the anterior leaf of vesicouterine ligament during the radical hysterectomy (type C)
-
Guangzhou, Guangdong, ChinaHuaiwu Lu
Jun 14, 2023
Lung Non-Small Cell Carcinoma, Stage I Lung Cancer AJCC v8, Stage IA1 Lung Cancer AJCC v8 Trial in Buffalo (Best Practice,
Not yet recruiting
- Lung Non-Small Cell Carcinoma
- +8 more
- Best Practice
- +2 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Dec 29, 2022
Stage IA NSCLC Trial in Seoul (Extent of pulmonary resection)
Recruiting
- Stage IA Non-small Cell Lung Cancer
- Extent of pulmonary resection
-
Seoul, Korea, Republic ofSamsung Medical Center
May 3, 2022
Localized Prostate Carcinoma, Locally Advanced Cervical Carcinoma, Locally Advanced Rectal Carcinoma Trial in Duarte (procedure,
Recruiting
- Localized Prostate Carcinoma
- +17 more
- Biospecimen Collection
- +4 more
-
Duarte, CaliforniaCity of Hope Medical Center
Feb 1, 2023
Chemotherapy Alone in Poor-differentiated Early-stage Cervical
Recruiting
- Cervical Cancer
-
Guangzhou, Guangdong, ChinaThe Sun Yat-Sen Memorial Hospital of Sun Yat-Sen Universit
May 16, 2023
Cervical Cancer, Prevention Trial in Ramotswa (Automated visual evaluation)
Active, not recruiting
- Cervical Cancer
- Prevention
- Automated visual evaluation
-
Ramotswa, BotswanaBamalete Lutheran Hospital
Feb 1, 2023
Radiomics-based Malnutrition for Cervical Cancer.
Not yet recruiting
- Cervical Cancer
- Malnutrition
- There are no interventions.
-
Hangzhou, Zhejiang, ChinaZhejiang Provincial People's Hospital
Jan 24, 2023
Cervical Adenocarcinoma, Cervical Adenosquamous Carcinoma, Cervical Squamous Cell Carcinoma, Not Otherwise Specified Trial in
Recruiting
- Cervical Adenocarcinoma
- +11 more
- Media Intervention
- +4 more
-
Houston, TexasM D Anderson Cancer Center
Jun 15, 2022
Stage IA Lung Cancer Trial in Shanghai (The disposable pulmonary radiofrequency ablation catheter and pulmonary radiofrequency
Not yet recruiting
- Stage IA Lung Cancer
- The disposable pulmonary radiofrequency ablation catheter and pulmonary radiofrequency ablation system
- The disposable percutaneous radiofrequency ablation needle and pulmonary radiofrequency ablation system
-
Shanghai, Shanghai, ChinaShanghai Chest Hospital
Sep 18, 2023
Cervical Cancer Trial in Nanning (tislelizumab, concurrent chemoradiotherapy)
Not yet recruiting
- Cervical Cancer
- tislelizumab
- concurrent chemoradiotherapy
-
Nanning, Guangxi, ChinaFirst Affiliated Hospital of Guangxi Medical University
Aug 22, 2022
Cervical Cancer Trial (Curcumin, Palliative radiotherapy)
Not yet recruiting
- Cervical Cancer
- Curcumin
- Palliative radiotherapy
- (no location specified)
Jul 14, 2023